BioCardia (BCDA) Sales of Property, Plant and Equipment (2011)
Analysis
BioCardia (BCDA) Sales of Property, Plant and Equipment (2011) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Sales of Property, Plant and Equipment (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.23 Bn | 9.38 Bn | 112.79 Mn | - |
| 2 | CRISPR Therapeutics AG | 5.03 Bn | 5.03 Bn | - | - |
| 3 | Iovance Biotherapeutics | 3.64 Bn | 3.35 Bn | 55.72 Mn | - |
| 4 | Legend Biotech | 3.53 Bn | 2.57 Bn | 251.50 Mn | - |
| 5 | uniQure | 2.99 Bn | 2.99 Bn | 5.49 Mn | - |
| 6 | Beam Therapeutics | 2.52 Bn | 2.52 Bn | - | - |
| 7 | Precigen | 2.39 Bn | 2.39 Bn | 52.17 Mn | - |
| 8 | Sarepta Therapeutics | 2.14 Bn | 1.35 Bn | 251.87 Mn | - |
| 9 | Vericel | 1.93 Bn | 1.77 Bn | 56.40 Mn | - |
| 10 | BioCardia | 13.00 Mn | 8.88 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2011 | 560,000.00 |
| Sep 30, 2011 | -411,000.00 |